AU2001278006A1 - Agonists of follicle stimulating hormone activity - Google Patents
Agonists of follicle stimulating hormone activityInfo
- Publication number
- AU2001278006A1 AU2001278006A1 AU2001278006A AU7800601A AU2001278006A1 AU 2001278006 A1 AU2001278006 A1 AU 2001278006A1 AU 2001278006 A AU2001278006 A AU 2001278006A AU 7800601 A AU7800601 A AU 7800601A AU 2001278006 A1 AU2001278006 A1 AU 2001278006A1
- Authority
- AU
- Australia
- Prior art keywords
- agonists
- stimulating hormone
- follicle stimulating
- hormone activity
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 title 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 229940028334 follicle stimulating hormone Drugs 0.000 title 1
- 230000003054 hormonal effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62924800A | 2000-07-27 | 2000-07-27 | |
| US09629248 | 2000-07-27 | ||
| PCT/US2001/023395 WO2002009706A1 (fr) | 2000-07-27 | 2001-07-24 | Agoniste d'activite hormonale stimulant un follicule |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001278006A1 true AU2001278006A1 (en) | 2002-02-13 |
Family
ID=24522195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001278006A Abandoned AU2001278006A1 (en) | 2000-07-27 | 2001-07-24 | Agonists of follicle stimulating hormone activity |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1307193A1 (fr) |
| JP (1) | JP2004505051A (fr) |
| AU (1) | AU2001278006A1 (fr) |
| CA (1) | CA2425889A1 (fr) |
| WO (1) | WO2002009706A1 (fr) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004017965A1 (fr) * | 2002-08-23 | 2004-03-04 | Ionix Pharmaceuticals Limited | 1,3-thiazolin-4-ones utilisees comme composes therapeutiques dans le traitement de la douleur |
| EP1542993B1 (fr) * | 2002-09-20 | 2012-12-19 | Merck Serono SA | Derives piperazine et procedes d'utilisation de ceux-ci |
| WO2005087765A1 (fr) * | 2004-03-04 | 2005-09-22 | Arena Pharmaceuticals, Inc. | Ligands du recepteur de l'hormone folliculo-stimulante et methodes d'utilisation associees |
| US7691848B2 (en) | 2005-03-02 | 2010-04-06 | Wyeth | Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists |
| UA92009C2 (ru) | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодия |
| UA92007C2 (ru) | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодности |
| UA92008C2 (en) | 2005-05-04 | 2010-09-27 | Н.В. Органон | 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
| WO2006117023A1 (fr) | 2005-05-04 | 2006-11-09 | N.V. Organon | Derives dihydropyridines |
| WO2006124581A2 (fr) | 2005-05-12 | 2006-11-23 | Wyeth | Pyrrolobenzodiazepines et derives de carboxamides heterocycliques constituant des antagonistes du recepteur de l'hormone folliculostimulante (fsh-r) |
| CA2609714A1 (fr) | 2005-06-09 | 2006-12-21 | Wyeth | Pyrrolobenzodiazepine pyridine carboxamides et derives utilises comme antagonistes du recepteur de l'hormone de stimulation folliculaire |
| CA2661827A1 (fr) * | 2006-08-23 | 2008-02-28 | Allergan, Inc. | Thiazolidinones, oxazolidinones therapeutiques associees, et composes associes |
| TW200944523A (en) | 2008-02-08 | 2009-11-01 | Organon Nv | (Dihydro)pyrrolo[2,1-a]isoquinolines |
| US8071587B2 (en) | 2009-05-27 | 2011-12-06 | N. V. Organon | (Dihydro)imidazoiso[5,1-A]quinolines |
| TW201116531A (en) | 2009-07-29 | 2011-05-16 | Organon Nv | Ring-annulated dihydropyrrolo[2,1-a]isoquinolines |
| US8431564B2 (en) | 2009-07-29 | 2013-04-30 | Merck Sharp & Dohme B.V. | Ring-annulated dihydropyrrolo[2,1-α]isoquinolines |
| TW201116515A (en) | 2009-07-31 | 2011-05-16 | Organon Nv | Dihydrobenzoindazoles |
| ES2796774T3 (es) | 2011-07-01 | 2020-11-30 | Merck Patent Gmbh | Dihidropirazoles, composiciones farmacéuticas de los mismos y su uso para el tratamiento de trastornos de fertilidad |
| CA2834199C (fr) | 2011-07-18 | 2020-01-07 | Merck Patent Gmbh | Benzamides |
| US9409897B2 (en) * | 2012-01-10 | 2016-08-09 | Merck Patent Gmbh | Benzamide derivatives as modulators of the follicle stimulating hormone |
| CN104114544A (zh) | 2012-02-08 | 2014-10-22 | 默克专利有限公司 | 用作卵泡刺激素受体激动剂的氘化噻唑烷酮类似物 |
| SG11201509411VA (en) | 2013-06-24 | 2015-12-30 | Merck Patent Gmbh | Pyrazole compounds as modulators of fshr and uses thereof |
| EP3013823B1 (fr) | 2013-06-24 | 2017-11-01 | Merck Patent GmbH | Composés imidazole servant de modulateurs des récepteurs de la fshr et leurs utilisations |
| US9399623B2 (en) | 2014-06-05 | 2016-07-26 | Merck Patent Gmbh | Quinoline derivatives and their use in neurodegenerative diseases |
| WO2015196335A1 (fr) | 2014-06-23 | 2015-12-30 | Tocopherx, Inc. | Composés de pyrazole utilisés comme modulateurs de fshr et leurs utilisations |
| AU2015296210B2 (en) | 2014-07-31 | 2019-08-15 | Merck Patent Gmbh | Indolizine derivatives which are applicable to neurodegenerative diseases |
| JP6680766B2 (ja) | 2014-09-05 | 2020-04-15 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | 癌治療のためのインドール−アミン−２，３−ジオキシゲナーゼ（ｉｄｏ）拮抗薬としてのシクロヘキシル−エチル置換ジアザ及びトリアザ三環化合物 |
| JP6673932B2 (ja) | 2014-12-15 | 2020-03-25 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | インドール及びアザインドール誘導体、並びに神経変性疾患におけるそれらの使用 |
| CN107011209A (zh) * | 2017-05-11 | 2017-08-04 | 蚌埠中实化学技术有限公司 | 一种3‑甲氧基‑4‑乙氧基苯腈的合成新工艺 |
| TW202435866A (zh) | 2023-03-08 | 2024-09-16 | 荷蘭商菲林公司 | 小分子ｆｓｈ受體調節劑 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3328415A (en) * | 1961-06-29 | 1967-06-27 | Sterling Drug Inc | 5-(2-hydroxyethyl)-4-thiazolidones and derivatives thereof |
| CH548411A (de) * | 1971-12-06 | 1974-04-30 | Ciba Geigy Ag | Verfahren zur herstellung von neuen 1,1-dioxothiazolidin4-onen. |
| US5061720A (en) * | 1989-09-13 | 1991-10-29 | A. H. Robins Company, Inc. | Substituted-4-thiazolidinone derivatives |
| GB9824614D0 (en) * | 1998-11-11 | 1999-01-06 | Glaxo Group Ltd | Chemical compounds |
-
2001
- 2001-07-24 CA CA002425889A patent/CA2425889A1/fr not_active Abandoned
- 2001-07-24 JP JP2002515259A patent/JP2004505051A/ja active Pending
- 2001-07-24 AU AU2001278006A patent/AU2001278006A1/en not_active Abandoned
- 2001-07-24 WO PCT/US2001/023395 patent/WO2002009706A1/fr not_active Ceased
- 2001-07-24 EP EP01955958A patent/EP1307193A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2425889A1 (fr) | 2002-02-07 |
| JP2004505051A (ja) | 2004-02-19 |
| EP1307193A1 (fr) | 2003-05-07 |
| WO2002009706A1 (fr) | 2002-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001278006A1 (en) | Agonists of follicle stimulating hormone activity | |
| AU2001278001A1 (en) | Agonist of follicle stimulating hormone activity | |
| AU2001231531A1 (en) | Follicle stimulating hormones | |
| AU2003207775A1 (en) | Long-acting follicle stimulating hormone analogues and uses thereof | |
| AU5963900A (en) | Muteins of bilin-binding protein | |
| AU2002230860A1 (en) | Skin desinfectant applicator | |
| AU7062400A (en) | Topical use of kappa opioid agonists to treat otic pain | |
| AU2002232544A1 (en) | Skin disinfectant applicator | |
| AU2002229087A1 (en) | Skin disinfectant applicator | |
| AU2001227815A1 (en) | Chemically specific imaging of tissue | |
| AU2001275860A1 (en) | Surgical prep solution applicator system and methods | |
| AU4996300A (en) | Method of electroporation-enhanced delivery of active agents | |
| AU2002246515A1 (en) | Medicated tattoos | |
| PL364720A1 (en) | Uses of ppar-gamma agonists in neutrophil-induced diseases | |
| EP1153602A4 (fr) | Preparations cutanees a usage externe | |
| AUPQ877300A0 (en) | Topical treatment of skin | |
| HUP0100790A3 (en) | Aqueous formulations of parasiticides for skin application | |
| AU3622600A (en) | Metalloproteinases and methods of use therefor | |
| AU5428700A (en) | Acrylic acid derivatives, use of the same and intermediates for the preparation thereof | |
| AU6917400A (en) | Use of 5-ht1b/1d agonists to treat otic pain | |
| AU2001275707A1 (en) | Use of panaxatriol for stimulation angiogenesis | |
| IL147891A0 (en) | Topical use of anti-muscarnic agents | |
| AU7106300A (en) | Treatment of skin disorders | |
| AU2001241771A1 (en) | Use of avocado-soybean unsaponifiable preparations | |
| AU2001232335A1 (en) | Skin preparations for external use |